Highlights

Autologous (patients own) cells taken from bone marrow

 “Prium Non Nocere“, which means “Not to harm”, as the treatment of any disease should not be more harmful than when leaving it untreated.

No profit objective

Unmanipulated  Mesenchymal stem cells

Presence of platelet and growth factor rich  plasma makes it more effective.

Point of care-so no risk of contamination

Cells maximum in no per ml compared to any enrichment tech available

Polyclonal in nature

No risk of rejection

Least side effects

Syringe containg stem cells can be made avaialble for cross verification

Route of administration individualised according to the disorder

Scientificaly monitored by a strict protocol.

Ficoll* not used 

As per the ICMR guidelines, these are done only as an experimental study